Loading…
Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes
Summary Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these f...
Saved in:
Published in: | Mycoses 2015-04, Vol.58 (4), p.215-219 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83 |
---|---|
cites | cdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83 |
container_end_page | 219 |
container_issue | 4 |
container_start_page | 215 |
container_title | Mycoses |
container_volume | 58 |
creator | Mayser, Peter |
description | Summary
Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases. |
doi_str_mv | 10.1111/myc.12300 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668259447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1668259447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</originalsourceid><addsrcrecordid>eNqNkUtPFUEQhTtEA1dk4R8wvdTFQL-me3ppbhRMuJIQ1OimqempDg3zwOm54PDrbbjAjsTaVFL5zknVKULecbbPcx10s9_nQjK2RRZcSVuwkplXZMGslIVRzOyQNyldMsaNFXqb7IhSG82MWpDzFTZx3VF_AbGnAaZppuBjQ3G6mFuKacIx0SLPpngDUxx6OgQK_RS76MehjpChENBPidYzXUELKeFdBIr93dxhekteB2gT7j32XfL9y-ez5VFxfHL4dfnpuPBKa1aUaLS0AjgGBrYuAbEJFWBTsxK58haCZ7bRotIqWFEy3_C6qmUFTBuoK7lLPmx8r8fhzzrv7bqYPLYt9Disk-NaV6K0Spn_QZXg0hqZ0Y8bNN-a0ojBXY-xg3F2nLn77F3O3j1kn9n3j7brusPmmXwKOwMHG-A2tji_7ORWv5ZPlsVGEfMf_j4rYLxy2khTup_fDt3vox-rU26EW8p_vGOdnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664213973</pqid></control><display><type>article</type><title>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Mayser, Peter</creator><creatorcontrib>Mayser, Peter</creatorcontrib><description>Summary
Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.</description><identifier>ISSN: 0933-7407</identifier><identifier>EISSN: 1439-0507</identifier><identifier>DOI: 10.1111/myc.12300</identifier><identifier>PMID: 25676074</identifier><language>eng</language><publisher>Germany: Blackwell Publishing Ltd</publisher><subject>Antifungal Agents - pharmacology ; antimicrobial effects ; atopic dermatitis ; Candida ; Candida - drug effects ; Caprylates - pharmacology ; Chromatography, Thin Layer ; Esters - pharmacology ; ethyl esters ; Fatty Acids - pharmacology ; hydrolytic activity ; Malassezia ; Malassezia - drug effects ; Malassezia - enzymology ; Malassezia spp ; Microbial Sensitivity Tests ; Saccharomyces cerevisiae - drug effects ; targeting</subject><ispartof>Mycoses, 2015-04, Vol.58 (4), p.215-219</ispartof><rights>2015 Blackwell Verlag GmbH</rights><rights>2015 Blackwell Verlag GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</citedby><cites>FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25676074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayser, Peter</creatorcontrib><title>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</title><title>Mycoses</title><addtitle>Mycoses</addtitle><description>Summary
Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.</description><subject>Antifungal Agents - pharmacology</subject><subject>antimicrobial effects</subject><subject>atopic dermatitis</subject><subject>Candida</subject><subject>Candida - drug effects</subject><subject>Caprylates - pharmacology</subject><subject>Chromatography, Thin Layer</subject><subject>Esters - pharmacology</subject><subject>ethyl esters</subject><subject>Fatty Acids - pharmacology</subject><subject>hydrolytic activity</subject><subject>Malassezia</subject><subject>Malassezia - drug effects</subject><subject>Malassezia - enzymology</subject><subject>Malassezia spp</subject><subject>Microbial Sensitivity Tests</subject><subject>Saccharomyces cerevisiae - drug effects</subject><subject>targeting</subject><issn>0933-7407</issn><issn>1439-0507</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkUtPFUEQhTtEA1dk4R8wvdTFQL-me3ppbhRMuJIQ1OimqempDg3zwOm54PDrbbjAjsTaVFL5zknVKULecbbPcx10s9_nQjK2RRZcSVuwkplXZMGslIVRzOyQNyldMsaNFXqb7IhSG82MWpDzFTZx3VF_AbGnAaZppuBjQ3G6mFuKacIx0SLPpngDUxx6OgQK_RS76MehjpChENBPidYzXUELKeFdBIr93dxhekteB2gT7j32XfL9y-ez5VFxfHL4dfnpuPBKa1aUaLS0AjgGBrYuAbEJFWBTsxK58haCZ7bRotIqWFEy3_C6qmUFTBuoK7lLPmx8r8fhzzrv7bqYPLYt9Disk-NaV6K0Spn_QZXg0hqZ0Y8bNN-a0ojBXY-xg3F2nLn77F3O3j1kn9n3j7brusPmmXwKOwMHG-A2tji_7ORWv5ZPlsVGEfMf_j4rYLxy2khTup_fDt3vox-rU26EW8p_vGOdnA</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Mayser, Peter</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>M7N</scope></search><sort><creationdate>201504</creationdate><title>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</title><author>Mayser, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antifungal Agents - pharmacology</topic><topic>antimicrobial effects</topic><topic>atopic dermatitis</topic><topic>Candida</topic><topic>Candida - drug effects</topic><topic>Caprylates - pharmacology</topic><topic>Chromatography, Thin Layer</topic><topic>Esters - pharmacology</topic><topic>ethyl esters</topic><topic>Fatty Acids - pharmacology</topic><topic>hydrolytic activity</topic><topic>Malassezia</topic><topic>Malassezia - drug effects</topic><topic>Malassezia - enzymology</topic><topic>Malassezia spp</topic><topic>Microbial Sensitivity Tests</topic><topic>Saccharomyces cerevisiae - drug effects</topic><topic>targeting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayser, Peter</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Mycoses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayser, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</atitle><jtitle>Mycoses</jtitle><addtitle>Mycoses</addtitle><date>2015-04</date><risdate>2015</risdate><volume>58</volume><issue>4</issue><spage>215</spage><epage>219</epage><pages>215-219</pages><issn>0933-7407</issn><eissn>1439-0507</eissn><abstract>Summary
Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.</abstract><cop>Germany</cop><pub>Blackwell Publishing Ltd</pub><pmid>25676074</pmid><doi>10.1111/myc.12300</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0933-7407 |
ispartof | Mycoses, 2015-04, Vol.58 (4), p.215-219 |
issn | 0933-7407 1439-0507 |
language | eng |
recordid | cdi_proquest_miscellaneous_1668259447 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Antifungal Agents - pharmacology antimicrobial effects atopic dermatitis Candida Candida - drug effects Caprylates - pharmacology Chromatography, Thin Layer Esters - pharmacology ethyl esters Fatty Acids - pharmacology hydrolytic activity Malassezia Malassezia - drug effects Malassezia - enzymology Malassezia spp Microbial Sensitivity Tests Saccharomyces cerevisiae - drug effects targeting |
title | Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A22%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medium%20chain%20fatty%20acid%20ethyl%20esters%20-%20activation%20of%20antimicrobial%20effects%20by%20Malassezia%20enzymes&rft.jtitle=Mycoses&rft.au=Mayser,%20Peter&rft.date=2015-04&rft.volume=58&rft.issue=4&rft.spage=215&rft.epage=219&rft.pages=215-219&rft.issn=0933-7407&rft.eissn=1439-0507&rft_id=info:doi/10.1111/myc.12300&rft_dat=%3Cproquest_cross%3E1668259447%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1664213973&rft_id=info:pmid/25676074&rfr_iscdi=true |